Cost savings from the use of antenatal steroids to prevent respiratory distress syndrome and related conditions in premature infants

This publication has 20 references indexed in Scilit:

• Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: The NICHD neonatal research network
  American Journal of Obstetrics and Gynecology, 1995
• Methods of cost-effectiveness analysis: areas of consensus and debate
  Clinical Therapeutics, 1995
• The cost of improving the outcome for infants of birthweight 500-999 g in Victoria: THE VICTORIAN INFANT COLLABORATIVE STUDY GROUP
  Journal of Paediatrics and Child Health, 1993
• Estimated Costs of Different Treatments of the Respiratory Distress Syndrome in a Large Cohort of Preterm Infants of Less than 30 Weeks of Gestation
  Neonatology, 1992
• Cost implications of different approaches to the prevention of respiratory distress syndrome.
  Archives of Disease in Childhood, 1991
• What is the Actual Cost of Neonatal Intensive Care?
  International Journal of Technology Assessment in Health Care, 1991
• Fetal Pulmonary Maturity and Antenatal Diagnosis of Respiratory Distress Syndrome
  Obstetrical & Gynecological Survey, 1987
• The argument for prenatal administration of dexamethasone to prevent respiratory distress syndrome
  The Journal of Pediatrics, 1984
• Effects of antenatal dexamethasone administration in the infant: Long-term follow-up
  The Journal of Pediatrics, 1984
• Economic Evaluation of Neonatal Intensive Care of Very-Low-Birth-Weight Infants
  New England Journal of Medicine, 1983